Brief: Burning Rock Biotech Q2 Gross Profit Rises 21.6%
31/08/2023 07:38
Aug 31 (Reuters) - Burning Rock Biotech Ltd BNR.O :
* Q2 GROSS PROFIT ROSE 21.6 PERCENT TO 100.4 MILLION RMB
* Q2 REVENUE ROSE 11.8 PERCENT TO 146.3 MILLION RMB
* Q2 GROSS PROFIT EXCLUDING ITEMS ROSE 20.3 PERCENT TO 109.4
MILLION RMB
Source text for Eikon: ID:nRSe9287Ka
Further company coverage: BNR.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Burning Rock Biotech
See all newsBurning Rock Biotech's Q2 revenue falls, net loss widens on central laboratory weakness
China's Burning Rock Biotech Q1 revenue falls on lower test volumes
China's Burning Rock Biotech Q4 net loss narrows as costs fall
Cancer diagnostics firm Burning Rock Biotech's Q3 revenue rises on pharma R&D growth
Brief: Burning Rock's Oncoguide™ Oncoscreen™ Plus CDX System Now Approved In Japan As A Companion Diagnostic For Capivasertib In Breast Cancer